The drug for Alzheimer’s disease given the green light by safety regulators in the United Kingdom on Thursday will not be funded by the NHS. That means it won't be available for purchase on NHS and patients will need to buy it privately.

New Alzheimer’s drug too costly, benefits too small, UK's health body says. 'Just not enough...'

alzheimers-drug-0

Alzheimer’s Drug, News on Alzheimer’s Drug, stories on Alzheimer’s Drug, articles on Alzheimer’s Drug, Alzheimer’s Drug stories at Wion, Alzheimer’s Drug news, Alzheimer’s Drug latest news

alzheimers drug-0

New Alzheimer’s drug too costly, benefits too small, UK's health body says. 'Just not enough...'